Pacific Biosciences of California, Inc.
PACB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$309,851 | -$306,735 | -$314,248 | -$181,223 |
| Dep. & Amort. | $53,338 | $32,691 | $17,318 | $11,585 |
| Deferred Tax | -$205 | -$11,424 | $0 | -$93,649 |
| Stock-Based Comp. | $0 | $0 | $78,613 | $80,728 |
| Change in WC | -$40,578 | -$58,957 | -$53,972 | $21,005 |
| Other Non-Cash | $91,238 | $77,877 | $9,078 | $50,374 |
| Operating Cash Flow | -$206,058 | -$266,548 | -$263,211 | -$111,180 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$6,188 | -$8,843 | -$16,929 | -$5,931 |
| Net Acquisitions | $0 | -$102 | $179 | -$319,793 |
| Inv. Purchases | -$498,635 | -$756,567 | -$442,788 | -$988,046 |
| Inv. Sales/Matur. | $628,827 | $770,116 | $575,800 | $635,239 |
| Other Inv. Act. | $0 | $0 | -$179 | $0 |
| Investing Cash Flow | $124,004 | $4,604 | $116,083 | -$678,531 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$50,690 | -$1,842 | -$1,608 | $895,175 |
| Stock Issued | $7,703 | $204,519 | $11,230 | $294,845 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$86,411 | $0 | -$20,439 |
| Financing Cash Flow | -$42,987 | $116,266 | $9,622 | $1,169,581 |
| Forex Effect | $890 | $500 | $0 | $0 |
| Net Chg. in Cash | -$124,151 | -$145,178 | -$137,506 | $379,870 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $180,211 | $325,389 | $465,817 | $85,947 |
| End Cash | $56,060 | $180,211 | $328,311 | $465,817 |
| Free Cash Flow | -$212,246 | -$275,391 | -$280,140 | -$117,111 |